Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02092233 · ClinicalTrials.gov registry record
A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients
A clinical trial, sponsored by Luminex Corporation.
- Completed
- Registry status
- 1,963
- Enrollment target
NCT02092233: Completed study, sponsored by Luminex Corporation.
NCT02092233 is a clinical trial that has completed, run by Luminex Corporation. The registered enrollment target is 1,963 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02092233 has completed, sponsored by Luminex Corporation.
- COMPLETED
- Registry status
- 1,963 participants
- Enrollment target
Study Summary
The ARIES HSV 1\&2 Assay is a PCR based test for the direct detection and typing of herpes simplex virus (HSV 1 \& 2) DNA. The objective is to establish the diagnostic accuracy of ARIES HSV-1\&2 Assay.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,963 participants |
| Start Date | 2014-01 |
What the finished NCT02092233 record still lists
NCT02092233 is an observational study that tracks outcomes without assigning an intervention. Its 1,963 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02092233 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02092233 about?
NCT02092233 is a clinical study titled "A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients". The ARIES HSV 1\&2 Assay is a PCR based test for the direct detection and typing of herpes simplex virus (HSV 1 \& 2) DNA. The objective is to establish the diagnostic accuracy of ARIES HSV-1\&2 Assay.
What is the current status of trial NCT02092233?
This trial is currently completed. The enrollment target is 1,963 participants. The study started on 2014-01.
Who is sponsoring clinical trial NCT02092233?
This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT06062394 · 1,980 participants · NA
Penn Medicine Healthy Heart
- NCT07321886 · 1,980 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia